Productos de contenido
Creditsafe deja a las compañías financieras elaborar cualquier continuación de el comportamiento financiero y también en la valoración crediticia de las clientes a través de una útil sobre análisis de Mensajes. (more…)
Контент-заметки
качество представлений в казино а также качество сервиса заказчиков имеют критическое большой удельный вес в видах онлайн-гемблинга. Прочный веб-обозрение будет вводить подробную оценку а также тамошнего, вдобавок альтернативного. Сие выручит геймерам брать на себя больше весовые вывода а также отрыть надежное казино.
Буква откликах пользователей должно особенно подчеркивать диверсификация игр, демократичных на онлайн-казино. (more…)
Explore how our innovative tissue engineering solutions can improve healing outcomes for millions of patients in India alone.
Artículos de objetivo
Los préstamos a plazos online resultan un clase de financiación cual suele facilitarte a construir en el caso de que nos lo olvidemos restaurar su historial crediticio. (more…)
Silk biomaterials offer unique properties to medical products, improving their safety and efficacy. Serigen's co-founder Dr. Premnath explains these advantages of silk protein.
Evaluating VIP Sweepstakes Sites to Play at in 2026 It’s worth trying them out even if you’re not a premium player already, as circumstances and criteria do change. Many US…
Silk biomaterials offer unique properties to medical products, improving their safety and efficacy. Serigen's co-founder Dr. Premnath explains these advantages of silk protein.
Infected wounds are tricky to manage and need the right wound dressing to expedite healing and control infections. Here is how Seriderm Ag serves this purpose.
Serigen wins the 9th National Award for Polymers in Public Healthcare by the Department of Chemicals and Petrochemicals, GoI Serigen has been awarded the 9th National Award for Polymers in…
Serigen wins the Poster Pitch Competition at the ORS 2024 Annual Meeting of the Orthopaedic Research Society, USA Serigen emerged as a winner in the Poster Pitch Competition at the…
Accomplished medical device professional. Over 25 years in leadership roles in New Product Development, Quality & Regulatory Affairs, Marketing, Sales and Business Development.Proven track record of managing new product development from concept to market. Hands-on expertise in Risk Management, Design Verification & Validation, Excellent problem-solving ability. Strong background of interaction with KOLs, customers and trade channels in India and EMEA. Ravi Sarangpani has completed his Production Engineering in 1989 from K.J Somaiya College of Engineering, Mumbai University.
Self Employed – 2019 onwards
Consulting and Advisory Services for medical device and healthcare companies and start-ups. Mentor at Venture Center, Asia’s largest science-based incubator and Materials Science Center, Indian Institute of Science, Bengaluru. Faculty at AIM-Prime, training & guidance program for deep tech startups, initiative of Atal Innovation Mission and Niti Aayog implemented by Venture Center, Pune.
Headed new product development for trauma, oncology and hip replacement for APAC region, 20-member team, USD 1m budget. Launched four new products in five years within budgets and targeted timelines. Implemented effective project management within a crossfunctional, multi-national, multi-locational project team. Developed and implemented design control procedure as per revised MDR that was adopted as model for implementation across sites.
Headed Design, Quality and Regulatory Functions. Implemented structured D&D methodology, cross functional teams, ‘first time right’ culture for execution efficiency. Started in-house design verification including computational modeling and testing. Implemented GD&T across team and manufacturing organization. Launched 3 new products that contributed to successful clinical outcomes for 15000+ patients between 2012 – 2018. Designed innovative locking plate system for fractures that was granted patents in U.S, EU, Japan.
Joined in start-up stage, grew business from $150k in 1993 to $3.6m by 2009. Established strong brand image and presence across India and 29 other countries. Developed KOL relationships that led to strong clinician driven product development.
